199 related articles for article (PubMed ID: 6143140)
1. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
[TBL] [Abstract][Full Text] [Related]
2. Osteomalacia in a patient with Paget's bone disease treated with long-term etidronate.
Hoppé E; Masson C; Laffitte A; Chappard D; Audran M
Morphologie; 2012 Aug; 96(313):40-3. PubMed ID: 23022200
[TBL] [Abstract][Full Text] [Related]
3. Osteomalacia in Paget's disease treated with short term, high dose sodium etidronate.
Gibbs CJ; Aaron JE; Peacock M
Br Med J (Clin Res Ed); 1986 May; 292(6530):1227-9. PubMed ID: 3085789
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous fractures in a patient treated with low doses of etidronic acid (disodium etidronate).
Eyres KS; Marshall P; McCloskey E; Douglas DL; Kanis JA
Drug Saf; 1992; 7(2):162-5. PubMed ID: 1605902
[TBL] [Abstract][Full Text] [Related]
5. Pathologic fracture due to severe osteomalacia following low-dose diphosphonate treatment of Paget's disease of bone.
Evans RA; Dunstan CR; Hills E; Wong SY
Aust N Z J Med; 1983 Jun; 13(3):277-9. PubMed ID: 6416243
[TBL] [Abstract][Full Text] [Related]
6. The treatment of Paget's bone disease with sodium ethidronate.
Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
[TBL] [Abstract][Full Text] [Related]
7. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate].
Pinel B; Cambon C; Thomine JM; Cauvin M; Daragon A; Deshayes P
Rev Rhum Mal Osteoartic; 1984; 51(7-8):417-8. PubMed ID: 6436959
[No Abstract] [Full Text] [Related]
8. Gross vertebral collapse associated with long-term disodium etidronate treatment for pelvic Paget's disease.
MacGowan JR; Pringle J; Morris VH; Stamp TC
Skeletal Radiol; 2000 May; 29(5):279-82. PubMed ID: 10883448
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of 10 cases of symptomatic Paget's disease with etidronate (EHDP)].
Jung A; Mermillod B; Schenk R; Courvoisier B; Burkhardt P; Epiney J; Fleisch
Schweiz Med Wochenschr; 1976 Nov; 106(48):1667-73. PubMed ID: 827810
[TBL] [Abstract][Full Text] [Related]
10. Effective short term treatment of Paget's disease with oral etidronate.
Preston CJ; Yates AJ; Beneton MN; Russell RG; Gray RE; Smith R; Kanis JA
Br Med J (Clin Res Ed); 1986 Jan; 292(6513):79-80. PubMed ID: 3080099
[TBL] [Abstract][Full Text] [Related]
11. Paget's bone disease treated with diphosphonate and calcitonin.
Hosking DJ; Bijvoet OL; van Aken J; Will EJ
Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
[TBL] [Abstract][Full Text] [Related]
12. Etidronate disodium in the treatment of Paget's disease of bone.
Krane SM
Ann Intern Med; 1982 May; 96(5):619-25. PubMed ID: 6280538
[TBL] [Abstract][Full Text] [Related]
13. Multiple fractures in a woman receiving 24 years of etidronate treatment for Paget's disease.
Labinson P; Taxel P
Conn Med; 2007 May; 71(5):269-73. PubMed ID: 17526382
[No Abstract] [Full Text] [Related]
14. Effects of ethane-1 hydroxy-1, 1-diphosphonate (5 mg/kg/day dose) on quantitative bone histology in Paget's disease of bone.
Alexandre C; Meunier PJ; Edouard C; Khairi RA; Johnston CC
Metab Bone Dis Relat Res; 1981; 3(4-5):309-15. PubMed ID: 6820112
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone.
Siris E; Weinstein RS; Altman R; Conte JM; Favus M; Lombardi A; Lyles K; McIlwain H; Murphy WA; Reda C; Rude R; Seton M; Tiegs R; Thompson D; Tucci JR; Yates AJ; Zimering M
J Clin Endocrinol Metab; 1996 Mar; 81(3):961-7. PubMed ID: 8772558
[TBL] [Abstract][Full Text] [Related]
16. [Non-hormonal drug treatment in Paget's disease].
Ryckewaert A; Lemaire V; Tubiana M
Rev Rhum Mal Osteoartic; 1975 Nov; 42(11):693-8. PubMed ID: 131365
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of Paget's disease with diphosphonate (disodium ethydronate)].
Caniggia A; Gennari C; Guideri R; Vattimo A; Nardi P
Minerva Med; 1976 Jan; 67(1):1-15. PubMed ID: 814505
[TBL] [Abstract][Full Text] [Related]
18. Small doses of etidronate (EHDP) and Paget's disease: meaning and importance of the decrease in plasmatic 25(OH)D3.
D'Amore M; Carrozzo M; Cantatore FP; Scagliusi P; Pipitone V
Panminerva Med; 1984; 26(1):13-7. PubMed ID: 6233523
[No Abstract] [Full Text] [Related]
19. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate.
Delmas PD; Chapuy MC; Edouard C; Meunier PJ
Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
